Z-0567-2016 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-0567-2016 was initiated by Becton Dickinson & Company on Dec 3, 2015 and is designated Class II. Reason for recall: Some of the Blood Collection Tubes in these lots were manufactured with insufficient EDTA additive. An insufficient EDTA additive may lead to erroneous platelet results, specimen recollection, or a… The recall status is terminated (terminated Oct 19, 2018). Affected quantity: 29,815,600 units in total.

Recall details

Product Type
Devices
Report Date
Jan 6, 2016
Initiation Date
Dec 3, 2015
Termination Date
Oct 19, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
29,815,600 units in total

Product description

BD Vacutainer PLUS K2EDTA Tubes (Plastic). 13 x 75 mm x 2.0 mL (Pink) BD Hemogard Additive: K2EDTA (spray dried), 3.6mg Sterile IVD BD, Made in USA The Vacutainer Brand PLUS (Plastic) Tube with EDTA Vacutainer¿ Brand Serum Tube are evacuated blood collection tubes which provide a means of collecting, transporting, separating and processing blood in a plastic tube.

Reason for recall

Some of the Blood Collection Tubes in these lots were manufactured with insufficient EDTA additive. An insufficient EDTA additive may lead to erroneous platelet results, specimen recollection, or a delay of treatment.

Distribution pattern

Worldwide Distribution: US (Nationwide) and the countries of: European Union, Peoples Republic of China, Japan and Republic of Korea.

Code information

Catalog Reference #367842; Lot numbers 5089731 and 5175923

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0567-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0567-2016. Report a data issue: hello@regdatalab.com.